Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Relating Prognosis in Chromophobe Renal Cell Carcinoma to the Chromophobe Tumor Grading System

´ëÇѺñ´¢±â°úÇÐȸÁö 2014³â 55±Ç 4È£ p.239 ~ 244
Weinzierl Elizabeth P, Thong Alan E, McKenney Jesse K, Àü½ÂÇö, Chung Benjamin I,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Weinzierl Elizabeth P ) 
Stanford University Medical Center Department of Pathology

 ( Thong Alan E ) 
Stanford University Medical Center Department of Urology
 ( McKenney Jesse K ) 
Stanford University Medical Center Department of Pathology
Àü½ÂÇö ( Jeon Seung-Hyun ) 
Kyung Hee University School of Medicine Department of Urology
 ( Chung Benjamin I ) 
Stanford University School of Medicine Department of Urology

Abstract


Purpose: The chromophobe subtype of renal cell carcinoma (chRCC) has generally been associated with a better prognosis than the clear cell type; however, debate continues as to absolute prognosis as well as the significance of certain prognostic variables. We investigated the significance of pathologic stage and a recently proposed chromophobe tumor grading (CTG) scheme in predicting chRCC outcomes.

Materials and Methods: All available chRCCs were identified from our surgical pathology archives from 1987-2010. Original slides were reviewed to verify diagnoses and stage, and each case was graded following a novel chromophobe tumor grade system criteria. Disease status was obtained from a clinical outcome database, and cancer specific deaths and recurrences were recorded.

Results: Eighty-one cases of chRCC were identified, and 73 had adequate follow-up information available. There were only 3 instances of cancer related recurrence or mortality, which included 1 disease specific mortality and 2 disease recurrences. Pathologic stage and CTG 3 were found to be significantly associated with the recurrences or death from chRCC, but there was no association with CTG 1 and CTG 2.

Conclusions: chRCC is associated with a very low rate of cancer specific events (4.1%) even at a tertiary referral center. In our study, pathologic stage and CTG 3, but not CTG 1 or 2, were significantly associated with the development of these events.

Å°¿öµå

Nephrectomy; Prognosis; Renal cell carcinoma

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS